Routine results of an algorithm for managing the production of blood components
- PMID: 38410835
- DOI: 10.1111/vox.13609
Routine results of an algorithm for managing the production of blood components
Abstract
Background and objectives: The variability in the number of donations together with a growing demand for platelet concentrates and plasma-derived medicines make us seek solutions aimed at optimizing the processing of blood. Some mathematical models to improve efficiencies in blood banking have been published. The goal of this work is to validate and evaluate an algorithm's impact in the production of blood components in the Blood and Tissues Bank of Aragon (BTBA).
Materials and methods: A mathematical algorithm was designed, implemented and validated through simulations with real data. It was incorporated into the fractionation area, which uses the Reveos® fractionation system (Terumo BCT) to split blood into its components. After 9 months of daily routine validation, retrospective activity data from the Blood Bank and Transfusion Services before and during the use of the algorithm were compared.
Results: Using the algorithm, the outdating rate of platelet concentrates (PC) decreased by 87.8% in the blood bank. The average shelf life remaining of PC supplied to Transfusion Services increased by almost 1 day. As a consequence, the outdating rate in the Aragon Transfusion Network decreased by 33%. In addition, extra 100 litres of plasma were obtained in 9 months.
Conclusions: The algorithm improves the blood establishment's workflow and facilitates the decision-making process in whole blood processing. It resulted in a decrease in PC outdating rate, increase in PC shelf life and finally an increase in the volume of recovered plasma, leading to significant cost savings.
Keywords: algorithm; optimization; platelet concentrate stocks; whole blood management.
© 2024 The Authors. Vox Sanguinis published by John Wiley & Sons Ltd on behalf of International Society of Blood Transfusion.
Similar articles
-
An ecosystem of interconnected technologies to increase efficiencies in blood establishments: The example of the Blood and Tissue Bank of Aragón, Spain.Vox Sang. 2025 Jan;120(1):32-38. doi: 10.1111/vox.13752. Epub 2024 Oct 23. Vox Sang. 2025. PMID: 39442933 Free PMC article.
-
Optimization of the management of platelet concentrate stocks in the Basque Country using mathematical simulation.Vox Sang. 2016 May;110(4):369-75. doi: 10.1111/vox.12377. Epub 2016 Feb 2. Vox Sang. 2016. PMID: 26830874
-
Platelet production planning to ensure availability while minimizing outdating.Transfusion. 1984 Nov-Dec;24(6):532-3. doi: 10.1046/j.1537-2995.1984.24685066819.x. Transfusion. 1984. PMID: 6506187
-
Is Platelet Expiring Out of Date? A Systematic Review.Transfus Med Rev. 2020 Jan;34(1):42-50. doi: 10.1016/j.tmrv.2019.08.006. Epub 2019 Oct 23. Transfus Med Rev. 2020. PMID: 31685352
-
[Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].Clin Lab. 2014;60(4):S1-39. doi: 10.7754/clin.lab.2014.140210. Clin Lab. 2014. PMID: 24779310 Review. German.
Cited by
-
An ecosystem of interconnected technologies to increase efficiencies in blood establishments: The example of the Blood and Tissue Bank of Aragón, Spain.Vox Sang. 2025 Jan;120(1):32-38. doi: 10.1111/vox.13752. Epub 2024 Oct 23. Vox Sang. 2025. PMID: 39442933 Free PMC article.
References
REFERENCES
-
- Stubbs JR, Homer MJ, Silverman T, Cap AP. The current state of the platelet supply in the US and proposed options to decrease the risk of critical shortages. Transfusion. 2021;61:303–312.
-
- Smethurst P, Cardigan R. Current challenges in platelet transfusion. Platelets. 2022;33:5–13.
-
- Kluszczynski T, Rohr S, Ernst R. White paper key economic and value considerations for plasma‐derived medicinal products (PDMPs) in Europe. 2020. Available from: https://www.vintura.com/wp‐content/uploads/2020/03/White‐paper‐key‐econo.... Last accessed 25 May 2023.
-
- Alter HJ. Pathogen reduction: a precautionary principle paradigm. Transfus Med Rev. 2008;22:97–102.
-
- Terumo BCT. Mirasol. 2023. Available from: https://www.terumobct.com/mirasol. Last accessed 25 May 2023.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials